- Home
- IRON vs STC Comparison
IRON vs STC Comparison
Compare IRON & STC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRON
- STC
- Stock Information
- Founded
- IRON 2017
- STC 1893
- Country
- IRON United States
- STC United States
- Employees
- IRON N/A
- STC N/A
- Industry
- IRON Biotechnology: Pharmaceutical Preparations
- STC Specialty Insurers
- Sector
- IRON Health Care
- STC Finance
- Exchange
- IRON Nasdaq
- STC Nasdaq
- Market Cap
- IRON 2.0B
- STC 2.0B
- IPO Year
- IRON N/A
- STC N/A
- Fundamental
- Price
- IRON $59.82
- STC $74.46
- Analyst Decision
- IRON Strong Buy
- STC Buy
- Analyst Count
- IRON 10
- STC 2
- Target Price
- IRON $97.80
- STC $77.50
- AVG Volume (30 Days)
- IRON 301.7K
- STC 147.6K
- Earning Date
- IRON 11-11-2025
- STC 10-22-2025
- Dividend Yield
- IRON N/A
- STC 2.68%
- EPS Growth
- IRON N/A
- STC 99.80
- EPS
- IRON N/A
- STC 3.11
- Revenue
- IRON N/A
- STC $2,668,739,000.00
- Revenue This Year
- IRON N/A
- STC $13.62
- Revenue Next Year
- IRON N/A
- STC $12.41
- P/E Ratio
- IRON N/A
- STC $23.99
- Revenue Growth
- IRON N/A
- STC 13.92
- 52 Week Low
- IRON $30.82
- STC $56.39
- 52 Week High
- IRON $68.73
- STC $78.44
- Technical
- Relative Strength Index (RSI)
- IRON 50.30
- STC 60.94
- Support Level
- IRON $58.59
- STC $71.44
- Resistance Level
- IRON $61.27
- STC $75.19
- Average True Range (ATR)
- IRON 2.13
- STC 1.77
- MACD
- IRON -0.15
- STC -0.11
- Stochastic Oscillator
- IRON 18.47
- STC 80.44
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
About STC Stewart Information Services Corporation
Stewart Information Services Corp is a customer-focused, title insurance and real estate services company offering products and services to home buyers and sellers, mortgage lenders and servicers, attorneys, and home builders. It has three operating segments; Title insurance and related services which generates key revenue, includes the functions of searching, examining, closing, and insuring the condition of the title to real property. It also includes home and personal insurance services, Real estate solutions segment supports the real estate mortgage industry by providing appraisal management services, online notarization and closing solutions, credit, and real estate information services, search and valuation services. Corporate and other segment is comprised of parent holding company.